4Filed Jul 27, 8:00 PM ET

Tenet Healthcare (THC) Director James L. Bierman Sells 5,000 Shares

$THC · TENET HEALTHCARE CORP

Research Summary

AI-generated summary of this SEC filing

Updated

Tenet Healthcare (THC) Director James L. Bierman Sells 5,000 Shares

What Happened

  • James L. Bierman, a director of Tenet Healthcare Corporation (THC), sold 5,000 shares in an open-market transaction on July 27, 2026. The weighted-average sale price was $244.96 per share, producing proceeds of approximately $1,224,800. The filing lists the transaction as a sale (code S).

Key Details

  • Transaction date: 2026-07-27; filing date: 2026-07-28 (filed the next day).
  • Price: weighted average $244.96; individual sale prices ranged from $244.95 to $245.29 (see footnote).
  • Shares sold: 5,000; proceeds: ~$1,224,800.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnote: The reported price is the weighted-average sales price across multiple transactions; the filer will provide a breakdown of shares sold at each price on request (footnote F1).
  • Transaction type: Open-market sale by a director (not an option exercise, award, or gift).

Context

  • This was a straightforward open-market sale by a company director. Sales by insiders can be routine (e.g., portfolio rebalancing or liquidity needs) and do not, by themselves, prove a change in outlook or company fundamentals. No indication in the filing of option exercises, awards, tax withholding, or 10% owner activity.